Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2026-01-19 @ 11:16 AM
Study NCT ID:
NCT05663866
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-23
First Post:
2022-12-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-16
First Submit QC Date:
None
Study First Post Date:
2022-12-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-03
Results First Submit QC Date:
None
Results First Post Date:
2025-10-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-03-04
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED